-
1 Comment
Jiangsu Lianhuan Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 6.7% below its 200 day moving average.
From a valuation standpoint, the stock is 82.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.7.
Jiangsu Lianhuan Pharmaceutical Co., Ltd's total revenue rose by 4.9% to $421M since the same quarter in the previous year.
Its net income has increased by 31.3% to $24M since the same quarter in the previous year.
Finally, its free cash flow grew by 11.6% to $-21M since the same quarter in the previous year.
Based on the above factors, Jiangsu Lianhuan Pharmaceutical Co., Ltd gets an overall score of 4/5.
| CurrencyCode | CNY |
|---|---|
| ISIN | CNE000001DP6 |
| Exchange | SHG |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Beta | 0.44 |
|---|---|
| Target Price | None |
| Market Cap | 3B |
| PE Ratio | 31.03 |
| Dividend Yield | None |
Jiangsu Lianhuan Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals, preparations, and API products in China and internationally. The company offers clopidogrel bisulfate tablets to prevent atherothrombotic events; doxycycline hydrochloride tablets for upper respiratory tract infections, tonsilitis, biliary tract infections, lymphadenitis, cellulitis, and chronic bronchitis; azithromycin tablets for the treatment of mild to moderate infections caused by susceptible strains of designated microorganisms; milrinone injection for short-term intravenous therapy in patients with acute compensated heart failure; dapoxetine hydrochloride tablets to treat premature ejaculation; tadafil tablets for erectile dysfunction; and bepotastine besilate tablets. It also provides aiplete tablets to treat benign prostatic hyperplasia; ebastine tablets for allergic rhinitis; felodipine tablets for mild to moderate essential hypertension; drotaverine hydrochloride injection to treat smooth muscle spasms caused by gastrointestinal diseases and to relieve dysmenorrhea; danazol suppositories to treat endometriosis; and terfenadine tablets for allergic rhinitis, perennial allergic rhinitis, and acute and chronic urticaria, as well as preparation products, which covers urinary system, antihistamines, cardiovascular drugs, steroid hormones, and antibiotics. In addition, the company engages in the wholesale of chemical raw materials and pharmaceuticals; sale of medical equipment and electronic products; and provision of medical technology research and development, and technological transfer services. It exports its products to Southeast Asia, North America, South America, Europe, New Zealand, Australia, and other countries. Jiangsu Lianhuan Pharmaceutical Co., Ltd. was founded in 1999 and is headquartered in Yangzhou, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600513.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
